asco

Views & Analysis

Digital tools key to immuno-oncology’s future: report

If ASCO 2021 proves anything, it’s that the explosion in immuno-oncology therapies over the last few years shows no signs of slowing down.

Views & Analysis

Deep Dive: Oncology 2021

This has probably been the toughest year for oncology researchers in memory.

Views & Analysis

Helping HCPs navigate the ever-evolving advanced cancer land...

OPEN Health’s Christine Drewienkiewicz, Sara Black and Annie Rankin on advances in modern oncology and how pharma can help ensure maximum patient benefit

Views & Analysis

ASCO 2020: Scientific advances & what’s impacting doctors an...

Despite going virtual due to the COVID-19 pandemic, Jennifer Harris, an immuno-oncology expert from Syneos Health told pharmaphorum’s Richard Staines that the 2020 American Society of Clini

Views & Analysis

ASCO 2020 round-up: Virtual conference still delivers the dr...

ASCO may have been virtual this year because of the COVID-19 pandemic, but there were still some show-stopping moments, reports Richard Staines. This time of year oncologists from

Oncology

ASCO 2020 virtual annual meeting - day 3

Our live coverage from this year’s slimmed down, virtual version of the American Society of Clinical Oncology (ASCO) annual meeting continues at 8am (ET) as we move into the third and final